BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress Read more about BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
BioNTech Completes Acquisition of Neon Therapeutics Read more about BioNTech Completes Acquisition of Neon Therapeutics
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program Read more about Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020 Read more about BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany Read more about BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates Read more about BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development Read more about Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
BioNTech Announces Full Year 2019 Financial Results and Corporate Update Read more about BioNTech Announces Full Year 2019 Financial Results and Corporate Update
BioNTech to report full year financial results for 2019 and provide corporate update on the fourth quarter on March 31, 2020 Read more about BioNTech to report full year financial results for 2019 and provide corporate update on the fourth quarter on March 31, 2020
